Anthony Stein
Associate Director, Gehr Family Center for Leukemia Research · City of Hope National Medical Center
Credentials: · · · · ·
History
- 1982–1985
- 1978–1979
- 1974–1978
1978, University of Cape Town Medical School, Cape Town, South Africa, M.B., Ch, B.
Research
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
New England Journal of Medicine · 2017 · 1,730 citations
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML
New England Journal of Medicine · 2018 · 1,234 citations
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Blood · 2017 · 1,232 citations
136 papers
108 papers
- VP
95 papers
93 papers
82 papers
- AS
75 papers
65 papers
63 papers
Grants
- 2015–2018
Image-Guided Irradiation Safely Intensifies HSCT Regimen for Refractory Leukemia
National Cancer Institute · R01
PI · $782.9K · Beckman Research Institute/City of Hope
Clinical trials
- 2022–2027
Principal investigator · Active not recruiting · Phase 1
City of Hope Medical Center
- 2018–2026
Principal investigator · Suspended · Phase 1
City of Hope Medical Center
- 2014–2027
Principal investigator · Active not recruiting · Phase 2
City of Hope Medical Center
- 2013–2014
Principal investigator · Terminated · Phase 1, Phase 2
Biosuccess Biotech Co., Ltd.